Document is current
Any future updates will be listed below
-
Authors
Parrish, Katelyn M.
First, Nicholas
Kamanova, Jana https://orcid.org/0000-0001-6574-4404
Williams, Tyler L.
Johnson, Sarah
King, Jaylyn
Scanlon, Karen M.
Azouz, Nurit P. https://orcid.org/0000-0003-4969-1263
Mattoo, Seema
Skerry, Ciaran https://orcid.org/0009-0009-3511-7472
Gestal, Monica C. https://orcid.org/0000-0001-7417-2460
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32HL155022-03)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20-GM134974)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI163595)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 12 September 2025
First Online: 20 October 2025
Competing interests
: Monica Cartelle Gestal submitted the patent titled: “Anti-IL-1RA as treatment for long-term bacterial infection” through LSU Health Sciences Center at Shreveport (PCT #2932719-000237-WO1; LSUHSC-S-2022-010-03). All other authors declare no competing interests for this paper.
